TrialBritish journal of pharmacology2001

A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine.

M Lördal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.